Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma
Minghao Li(Central South University), Christina Pamporaki(University Hospital Carl Gustav Carus), Jacques W.M. Lenders(Radboud University Nijmegen), Tamara Prodanov(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Annika M.A. Berends(University Medical Center Groningen), Graeme Eisenhofer(University Hospital Carl Gustav Carus), Henri Timmers(Radboud University Nijmegen), Nicole Bechmann(University Hospital Carl Gustav Carus), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Aleksander Prejbisz(Institute of Cardiology), Karel Pacák(Endocrine Society), Leah Meuter(Stanford Medicine), Svenja Nölting(University of Zurich), Stephanie Fliedner(University Hospital Schleswig-Holstein), Sara Talvacchio(National Institutes of Health), Michiel N. Kerstens(University Medical Center Groningen), Hanna Remde(University of Würzburg)
Cited by 36
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
|The Journal of Clinical Endocrinology & Metabolism|2005|711
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
|The Lancet Oncology|2009|536
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528